These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29744595)

  • 1. Synthesis and biocompatibility of an argatroban-modified polysulfone membrane that directly inhibits thrombosis.
    Fu X; Ning JP
    J Mater Sci Mater Med; 2018 May; 29(5):66. PubMed ID: 29744595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decoration of heparin and bovine serum albumin on polysulfone membrane assisted via polydopamine strategy for hemodialysis.
    Xie B; Zhang R; Zhang H; Xu A; Deng Y; Lv Y; Deng F; Wei S
    J Biomater Sci Polym Ed; 2016 Jun; 27(9):880-97. PubMed ID: 27018964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-methoxyethylacrylate modified polysulfone membrane and its blood compatibility.
    Tian X; Qiu YR
    Arch Biochem Biophys; 2017 Oct; 631():49-57. PubMed ID: 28764891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood compatibility and permeability of heparin-modified polysulfone as potential membrane for simultaneous hemodialysis and LDL removal.
    Huang XJ; Guduru D; Xu ZK; Vienken J; Groth T
    Macromol Biosci; 2011 Jan; 11(1):131-40. PubMed ID: 20878965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of blood compatibility on polysulfone-polyvinylpyrrolidone blend films as a model membrane of dialyzer by physical adsorption of recombinant soluble human thrombomodulin (ART-123).
    Omichi M; Matsusaki M; Maruyama I; Akashi M
    J Biomater Sci Polym Ed; 2012; 23(5):593-608. PubMed ID: 21310110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The hemocompatibility of the modified polysulfone membrane with 4-(chloromethyl)benzoic acid and sulfonated hydroxypropyl chitosan.
    Yan S; Tu MM; Qiu YR
    Colloids Surf B Biointerfaces; 2020 Apr; 188():110769. PubMed ID: 31918157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fabrication, Characterization, and Hemocompatibility Investigation of Polysulfone Grafted With Polyethylene Glycol and Heparin Used in Membrane Oxygenators.
    Zheng Z; Wang W; Huang X; Lv Q; Fan W; Yu W; Li L; Zhang Z
    Artif Organs; 2016 Nov; 40(11):E219-E229. PubMed ID: 28374499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced hydrophilicity and anticoagulation of polysulfone materials modified via dihydroxypropyl, sulfonic groups and chitosan.
    Wang C; Lin B; Qiu Y
    Colloids Surf B Biointerfaces; 2022 Feb; 210():112243. PubMed ID: 34861540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immobilizing argatroban and mPEG-NH
    Dai Y; Dai S; Xie X; Ning J
    J Biomater Sci Polym Ed; 2019 Jun; 30(8):608-628. PubMed ID: 30907698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface modification of polysulfone based hemodialysis membranes with layer by layer self assembly of polyethyleneimine/alginate-heparin: a simple polyelectrolyte blend approach for heparin immobilization.
    Mahlicli FY; Altinkaya SA
    J Mater Sci Mater Med; 2013 Feb; 24(2):533-46. PubMed ID: 23128985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemocompatibility and oxygenation performance of polysulfone membranes grafted with polyethylene glycol and heparin by plasma-induced surface modification.
    Wang W; Zheng Z; Huang X; Fan W; Yu W; Zhang Z; Li L; Mao C
    J Biomed Mater Res B Appl Biomater; 2017 Oct; 105(7):1737-1746. PubMed ID: 27177987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polysulfone hemodiafiltration membranes with enhanced anti-fouling and hemocompatibility modified by poly(vinyl pyrrolidone) via in situ cross-linked polymerization.
    Zhu L; Song H; Wang J; Xue L
    Mater Sci Eng C Mater Biol Appl; 2017 May; 74():159-166. PubMed ID: 28254281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel kind of polysulfone material with excellent biocompatibility modified by the sulfonated hydroxypropyl chitosan.
    Liu TM; Xu JJ; Qiu YR
    Mater Sci Eng C Mater Biol Appl; 2017 Oct; 79():570-580. PubMed ID: 28629055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immobilized heparin and its anti-coagulation effect on polysulfone membrane surface.
    Ren X; Xu L; Xu J; Zhu P; Zuo L; Wei S
    J Biomater Sci Polym Ed; 2013; 24(15):1707-20. PubMed ID: 23705787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteins adsorbed to a polysulfone hemodialysis membrane under heparin and citrate anticoagulation regimens.
    Mares J; Tuma Z; Moravec J; Pavlina R; Matejovic M
    Artif Organs; 2019 Nov; 43(11):1092-1103. PubMed ID: 31162876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covalent heparin modification of a polysulfone flat sheet membrane for selective removal of low-density lipoproteins: a simple and versatile method.
    Li J; Huang XJ; Ji J; Lan P; Vienken J; Groth T; Xu ZK
    Macromol Biosci; 2011 Sep; 11(9):1218-26. PubMed ID: 21728235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
    Dager WE; White RH
    Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood compatible aspects of DNA-modified polysulfone membrane-protein adsorption and platelet adhesion.
    Zhao C; Liu X; Nomizu M; Nishi N
    Biomaterials; 2003 Sep; 24(21):3747-55. PubMed ID: 12818547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum protein adsorption and platelet adhesion on aspartic-acid-immobilized polysulfone membranes.
    Higuchi A; Hashiba H; Hayashi R; Yoon BO; Sakurai M; Hara M
    J Biomater Sci Polym Ed; 2004; 15(8):1051-63. PubMed ID: 15461189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Argatroban: a direct thrombin inhibitor with reliable and predictable anticoagulant actions.
    Escolar G; Bozzo J; Maragall S
    Drugs Today (Barc); 2006 Apr; 42(4):223-36. PubMed ID: 16703119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.